Andrew J Larner. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAntiparkinson Agents/adverse effectsAntiparkinson Agents/therapeutic useDisruptive, Impulse Control, and Conduct Disorders/chemically inducedDisruptive, Impulse Control, and Conduct Disorders/psychologyDopamine Agonists/adverse effectsDopamine Agonists/therapeutic useDrug Therapy, CombinationGambling/psychologyHumansInternetLevodopa/adverse effectsLevodopa/therapeutic useMaleParkinson Disease/drug therapyParkinson Disease/psychologyPergolide/adverse effectsPergolide/therapeutic use
Substances: See more » Antiparkinson AgentsDopamine AgonistsPergolideLevodopa
Year: 2006 PMID: 16941457 DOI: 10.1002/mds.21057
Source DB: PubMed Journal: Mov Disord ISSN: 0885-3185 Impact factor: 10.338